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Cannabidiol (CBD) is the most abundant cannabinoid in Cannabis sativa that has no psychoactive properties. CBD has been
approved to treat inﬂammation, pain and spasticity associated with multiple sclerosis (MS), of which demyelination and
oligodendrocyte loss are hallmarks. Thus, we investigated the protective effects of CBD against the damage to oligodendrocyte
progenitor cells (OPCs) mediated by the immune system. Doses of 1lM CBD protect OPCs from oxidative stress by decreasing
the production of reactive oxygen species. CBD also protects OPCs from apoptosis induced by LPS/IFNc through the decrease
of caspase 3 induction via mechanisms that do not involve CB1, CB2, TRPV1 or PPARc receptors. Tunicamycin-induced OPC
death was attenuated by CBD, suggesting a role of endoplasmic reticulum (ER) stress in the mode of action of CBD. This
protection against ER stress-induced apoptosis was associated with reduced phosphorylation of eiF2a, one of the initiators of
the ER stress pathway. Indeed, CBD diminished the phosphorylation of PKR and eiF2a induced by LPS/IFNc. The pro-survival
effects of CBD in OPCs were accompanied by decreases in the expression of ER apoptotic effectors (CHOP, Bax and caspase
12), and increased expression of the anti-apoptotic Bcl-2. These ﬁndings suggest that attenuation of the ER stress pathway is
involved in the ‘oligoprotective’ effects of CBD during inﬂammation.
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Cannabidiol (CBD) is the most abundant cannabinoid in
Cannabis sativa that is devoid of psychoactive properties.
CBD exerts anti-inﬂammatory, antioxidant and neuroprotec-
tive effects,
1 and it has been approved for the treatment of
inﬂammation, pain and spasticity associated with multiple
sclerosis (MS).
2 Studies in an animal model of EAE have
shown that CBD ameliorates the severity of the disease by
attenuating neuroinﬂammation and axonal damage.
3 Oligo-
dendrocyte progenitor cells (OPCs) are relatively quiescent
cells derived from precursors of the perinatal CNS that make
up around 5–8% of the glial cell population in the adult; in the
injuredCNS,theycandivideandarethoughttodifferentiateto
new myelinating oligodendroytes that replace those that have
beenlostindemyelinatingareas.
4OPCsarehighlyvulnerable
to inﬂammation and oxidative stress as they have a high
metabolic rate, high intracellular iron, and low concentrations
of the antioxidative glutathione; they also express an arsenal
of molecules rendering them susceptible to inﬂammatory
cytokines or high calcium levels among others.
5 It is known
that inﬂammation contributes to oligodendroglial damage in
demyelinating diseases such as MS.
6 Synthetic cannabinoids
suchasWIN55212-2andHU211canprotectoligodendrocyte
progenitors cells (OPCs) from the apoptosis induced by the
withdrawal of trophic support,
7 although their utility is limited
due to their unwanted psychotropic effects. However, little is
known about the effects of CBD on the apoptosis of OPCs
induced by inﬂammation. Although CBD induces cytotoxicity
in oligodendrocytes of the optic nerve under basal conditions
by increasing intracellular calcium,
8 it also prevents apoptotic
signaling in neurons by reducing calcium inﬂux.
9 The
pharmacological basis of the effects of CBD remains elusive,
although multiple potential targets of CBD have been
proposed in function of the stimuli and cell type involved.
1
The endoplasmic reticulum (ER) stress response modu-
lates the response of oligodendrocytes to inﬂammatory
stimuli,
10 and it involves the activation of the double-stranded
RNA-activated serine/threonine kinase (PKR), which has
been implicated as an important component of host
responses to infection and various situations of cellular
stress.
11 PKR is one of the ER transmembrane protein factors
thatcoordinatesanadaptiveprogramknownastheintegrated
stress response by phosphorylating the translation initiation
1Department of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, Spain;
2Department of Physiology and Biophysics,
Institute of Biomedical Sciences, University of Sa ˜o Paulo, Sa ˜o Paulo, Brazil and
3Medicinal Chemistry Department, Institute of Drug Research, Hebrew University of
Jerusalem, Jerusalem, Israel
*Corresponding author: C Guaza, Department of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Avda. Dr. Arce 37, 28002
Madrid, Brazil. Tel: þ34 5854742; Fax: þ34 5854754; E-mail: cgjb@cajal.csic.es
Received 28.2.12; revised 08.5.12; accepted 11.5.12; Edited by D Bano
Keywords: cannabidiol; OPCs; inﬂammation; oxidative stress; ER stress; multiple sclerosis
Abbreviations: ATF-6, activation transcription factor 6; BrdU, 5-bromo-2’-deoxyuridine; CB1, cannabinoid receptor type 1; CB2, cannabinoid receptor type 2; CBD,
cannabidiol; DCF-DA, 2’,7’-dichloroﬂuorescein-diacetate; eiF2a, translation initiation factor 2a; ER, endoplasmic reticulum; IFNg, interferon-gamma; IRE1a, inositol-
requiring enzyme 1a; ROS, reactive oxygen species; LPS, lipopolysaccharide; MS, multiple sclerosis; NO, nitric oxide; NOS-2, nitric oxide syntase-2; OPCs,
oligodendrocyte precursor cells; PKR, double-stranded RNA-activated serine/threonine kinase; PPARg, peroxisome proliferator-activated receptor gamma; RT-PCR,
reverse transcription PCR; TRPV1, transient receptor potential cation channel subfamily V member 1; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end
labeling; UPR, unfolded protein response
Citation: Cell Death and Disease (2012) 3, e331; doi:10.1038/cddis.2012.71
& 2012 Macmillan Publishers Limited All rights reserved 2041-4889/12
www.nature.com/cddisfactor 2a (eIF2a).
12 Oligodendrocytes produce vast amounts
of myelin and they are highly sensitive to homeostatic
changes in the ER.
10 The most rapidly activated pathway in
conditions of ER stress involves translational repression,
which can be mediated by the activation of PKR among
others,andresultsinthephosphorylationofeiF2a.
13Although
this pathway appears to offer cytoprotection to a variety of cell
types,
14 it can also activate apoptosis in others
15; particularly
in oligodendrocytes the ER stress outcome may be deter-
mined by the developmental status of the cell, as in fully
myelinated mature oligodendrocytes it promotes cell survival,
butinactivelymyelinating/remyelinatingoligodendrocytesleads
to cell death.
10 Indeed, ER stress has been linked with the
apoptosis of myelinating oligodendrocytes induced by IFNg
16
and during ischemia.
17 Moreover, several human diseases that
involvedemyelination/hypomyelinationappeartoinvolveaggra-
vated ER stress. In Charcot–Marie–Tooth disease,
18 Vanishing
White Matter disease,
19,20 and even in immune-mediated
demyelinating disorders such as MS,
21 severe ER stress and
activation of the unfolded protein response (UPR) are con-
sidered central to the pathogenesis of the disease.
In the present study, we provide evidence that CBD offers
protectionto OPCsagainst inﬂammation-induced damage,as
well as protecting OPCs from oxidative stress by decreasing
ROS production. Finally, we demonstrate that the protective
effects of CBD against inﬂammatory damage and ER stress
are associated with modiﬁcations in the expression of
apoptotic effectors of the UPR.
Results
Dose–response studies of the effects of CBD on OPCs.
As CBD has different effects on distinct cell types, we
evaluated its effects on primary OPC cultures under basal
conditions. In dose–response experiments (0.1, 1, 2.5 and
5mM) CBD failed to induce cell death at low concentrations (0.1
and 1mM: Figure 1a), although some cytotoxicity was observed
at higher concentrations, resulting in the death of 23.38±3.98%
of cells (Pp0.01) after a 24-h exposure to 2.5mM CBD, and of
33.13±5.6% (Pp0.001) at 5mM. Based on these ﬁndings, a
dose of 1mM was selected for the subsequent experiments.
WenextinvestigatedtheeffectofCBD(1mM)onthecellcycle
by evaluating OPC proliferation. Quantiﬁcation of BrdU
þ cells in
OPC primary cultures (n¼10000 cells, Figure 1b) revealed that
CBD did not increase the proliferation of OPCs in vitro
(47.65±8.61%) with respect to the controls (48.21±10.5%).
Theseresultswereconﬁrmedbysubsequentlyanalyzingthecell
cycle by ﬂowcytometry(Figure 1c),in whichno differenceswere
observed between G0/G1, S and G2/M phases.
At doses of 0.1 and 1mM, CBD has been reported to
increase intracellular Ca
2þ and to induce oligodendrocyte
death in the optic nerve.
8 Thus, we investigated whether 1mM
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Figure 1 Effects of CBD on OPCcytotoxicity.(a)Although CBDdid not inducecell death at low concentrations (0.1and 1mM), cytotoxiceffects wereobservedat 2.5and
5mM. OPCs were exposed to CBD and cell death was quantiﬁed 48h later using the LDH method. Data represent the mean±S.E.M. of n¼3 cultures analyzed in triplicate.
Statistical signiﬁcance was determined by a one-way ANOVA: **Pp0.01 and ***Pp0.001 versus untreated cells. (b) CBD did not augment OPC proliferation evident as an
increase in BrdU incorporation. OPCs were incubated with BrdU (10mM) for 24h and at least 10000 cells were then quantiﬁed by immunocytochemistry. (c) Flow cytometry
analysis revealed the CBD does not affect the cell cycle progression of OPCs. Freshly isolated OPCs were incubated for 24h in the presence or absenceof CBD (1mM), and
the cell cycle of a minimum of 10000 cells was analyzed on a FACSAria ﬂow cytometer following PI staining. (d, e) CBD did not alter intracellular Ca
2þ levels under basal
conditions.OPCswereloaded with the Ca
2þ-sensitivedye Fluo-4and theﬂuorescencesignalwas monitored on a scanningconfocalmicroscopeunder basalconditionsand
afteraddingCBD(1mM:n¼5coverslips).(d)RepresentativepseudocolorimagesshowingCa
2þ levelsinculturedOPCsunderbasalconditionsandinthepresenceofCBD
(1mM). Scale bar¼50mm. (e) Fluorescence traces showingthe Ca
2þ time course in individual OPCs (n¼8) from the experiment shown in (d), both under basal conditions
and in the presence of CBD.
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Cell Death and DiseaseCBD-induced Ca
2þ release from intracellular stores in
cultured OPCs loaded with the Ca
2þ-sensitive dye, Fluo-4.
There was no difference in the ﬂuorescence signal obtained
under basal conditions and in the presence of CBD
(1mM: Figures 1d and e), indicating that intracellular Ca
2þ
levels were not signiﬁcantly modiﬁed by CBD.
CBD protects OPCs from inﬂammatory stimuli and from
apoptosis in a cannabinoid receptor-independent
manner. As we previously reported that the LPS/IFNg
inﬂammatory stimuli induced cytotoxicity in OPCs,
22 it was
noteworthy that CBD (1mM) protected OPCs from the
noxious effects of inﬂammation (Pp0.001, Figure 2a),
decreasing cell death from 37.84±4.95% to 10.41±4.41%.
Indeed, the induction of the apoptotic effector caspase 3
(Figure 2b) by LPS/IFNg was reversed by the treatment with
CBD (Pp0.05), and the number of TUNEL
þ cells
(24.35±1.54%) fell to control levels in the presence of
CBD (3.34±0.96%, Pp0.001) when quantiﬁed 24h post
treatment (Figures 2c and d). To investigate the mechanisms
underlying the oligoprotection offered by CBD, antagonists of
CB1, CB2, TRPV1 and PPARg receptors were administered
before the LPS/IFNg insult in the presence and absence of
CBD. None of these antagonists reversed the protective
effects of CBD observed in inﬂammatory conditions, sug-
gesting that the effects of CBD are not mediated by these
receptors (Figure 2a).
CBD rescues OPCs from H2O2-induced death by
decreasing ROS production. CBD is a resorcinol-based
compound with direct and potent antioxidant properties;
23
hence, we investigated whether CBD acts as an antioxidant
in OPCs subjected to oxidative stress by evaluating its
effects on the cell death and ROS production induced by
hydrogen peroxide (100mM). CBD prevented the detachment
and swelling of OPCs induced by direct oxidative stress
(Figure 3a), and decreased cell death from 84.89±6.93% to
39.12±1.82% (Pp0.01, Figure 3b). Moreover, this effect
was accompanied by a decrease in ROS production,
as determined in DCF-DA assays 1h post treatment (H2O2þ
vehicle, 216.63±15.7%; H2O2þCBD, 151.59±5.10%:
Pp0.001, Figure 3c). To separate the antioxidant properties
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Figure 2 CBD protectsagainstinﬂammatorydamagebydiminishingapoptosisanddecreasesthenumberof TUNEL
þ OPCsthrougha mechanismthatdoesnotinvolve
CB1,CB2,TRPV1orPPARgreceptors.(a)LPS/IFNg-inducedcytotoxicityinOPCswasattenuatedbyCBD,adoseof1mMprovingtobethemosteffective).Administrationof
CB1,CB2,TRPV1orPPARgantagonists(SR1,AM639,CPZ:1mMandGW9662:50nM)30minbeforethestimulushadnoeffect,indicatingthatnoneofthesereceptorsare
implicated in the protective effects of CBD. The data represent the mean±S.E.M. of n¼3 independent cultures analyzed in triplicate, and the statistical analysis was
performedusingKruskal–WallisANOVAfollowedbyMann–WhitneyUtest:***Pp0.001versusuntreatedcells,
#Pp0.05and
###Pp0.001versuscellsexposedtoLPS/IFNg
alone. (b) Cleaved caspase3 western blot shows that LPS/IFNg treatment induces the activation of the apoptotic pathway, whereas the co-treatment with CBD reduces this
induction. OPCs were incubated with LPS/IFNg in presence or absence of CBD (1mM). Total protein extracts were prepared 24h later and cleaved caspase 3 (19KDa) was
assessed in western blots probed with speciﬁc antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from three independent cultures
analyzed in triplicate, and statistical analysis was performed using one-way ANOVA followed by the Bonferroni post-hoc test: **Pp0.01 compared with non-treated cells,
#Pp0.05 compared with LPS/IFNg group. (c and d) A2B5 and TUNEL staining show that LPS/IFNg decreased OPC number by inducing apoptosis, an effect that was
reversedby CBD as previously conﬁrmedby caspase 3 measurement. OPCswere exposed for 24h to the cytotoxicstimulus, in the presenceor absenceof CBD (1mM), and
6000 OPCs cells were counted. Data represent the mean±S.E.M., and the statistical signiﬁcance was determined using the Kruskal–Wallis ANOVA followed by Mann–
Whitney U test: ***Pp0.001 versus untreated cells, and
###Pp0.001 versus cells exposed to LPS/IFNg alone
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Cell Death and Diseaseof CBD of its possible cytoprotective effects on OPCs during
inﬂammation, we also evaluated the effects of CBD on NO
production in response to LPS/IFN-g by measuring nitrites
and by western blot to assess NOS-2 expression, but CBD
was not able to modify NO production (data not shown).
ER stress induces OPC death, an effect that is
attenuated by CBD via decreased eiF2a phosphorylation.
As ER stress is implicated in several diseases with inﬂamma-
tory components, such as MS,
21 we analyzed primary OPC
death in response to activation of this cellular program.
Tunicamycin-induced ER stress led to OPC death 24h post
treatment (45.81±4.7%: Figure 4a), which was attenuated
by treatment with CBD (20.39±2.54%, Pp0.01). Exposure to
CBD also decreased the phosphorylation of the eiF2a protein
(Pp0.05), an initiator of the apoptotic pathway induced by
ER stress (Figure 4b). Interestingly, tunicamycin-induced ER
stress was not mediated by the phosphorylation of PKR, a
potential activators of eiF2a in the ER (data not shown).
CBD attenuates the activation of the ER apoptotic
pathway in inﬂammatory conditions. Given the link
between the mechanisms underlying inﬂammation and ER
stress recently reported,
24 we investigated the ER stress
response induced by LPS/IFNg. When we examined
the effect of LPS/IFN-g on PKR and eiF2a phosphorylation
in OPCs, an increase in the phosphorylation of these
proteins was evident in Western blots (Figures 4c and d).
Interestingly, CBD impaired this increase in PKR and
eiF2a phosphorylation, which remained at control levels
(Pp0.05), suggesting that one of the protective effects of
CBD in OPCs involves the reduction of ER stress during
neuroinﬂammation.
To conﬁrm the effects of CBD in combating the ER stress
associated with inﬂammation, we analyzed ER mediators
of the apoptotic pathway. CBD signiﬁcantly dampened the
induction of ER pro-apoptotic molecules by LPS/IFNg, such
as the initiator CHOP, a major ER stress marker, and the
effector caspase 12, as evident by real-time (RT)-PCR
(Pp0.01: Figure 5). In addition, the balance of pro-apoptotic
(Bax)andanti-apoptotic (Bcl-2)proteins, whichisderegulated
by LPS/IFNg treatment, returned to the basal state in the
presence of CBD (Pp0.05). Furthermore, the expression of
GADD34, a negative feedback protein in this pathway
augmented when OPCs were treated with CBD (Pp0.001),
suggesting that this cannabinoid represses this apoptotic
program.
Discussion
In this study, we show that the nonpsychotropic cannabinoid,
CBD,preventsOPCdeathinducedbyinﬂammatory,oxidative
or direct ER stress. CBD does not modify the OPC cell cycle
and its protective effect was unaltered by classical cannabi-
noid, vanilloid or PPARg receptor antagonists. Moreover, the
anti-apoptotic effect of CBD appears to be mediated by
decreasing the expression of pro-apoptotic effectors and
dampening the activity of the ER stress pathway. These
ﬁndings deﬁne a novel mode of action for CBD in OPCs,
supporting its therapeutic potential to protect OPCs in
pathologies involving demyelination.
Neuroinﬂammation is one of the primary mechanisms
underlying the pathogenesis of MS, and proinﬂammatory
mediators are considered key effectors of the damage
in demyelinating disorders. Indeed, previous studies have
shown that inﬂammatory stimuli induce apoptosis in
OPCs.
6,22 When we initially studied the effects of CBD on
primary OPC cultures, cytotoxic effects were only observed at
doses 42.5mM. At doses of 0.1 and 1mM, CBD was
previously reported to increase intracellular calcium and
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Figure3 OxidativestressinducedbyH2O2inducesOPCdetachmentanddeath,aneffectthatwasattenuatedbyCBDbydecreasingROSproduction.(a)Phasecontrast
images ( 10) show that treatment with H2O2 induced the swelling and detachment of OPCs, an effect prevented by CBD treatment. (b) CBD protects OPCs from oxidative
stress. OPCs were treated with H2O2 in the presence or absence of CBD (1mM) and cell death was quantiﬁed 18h later using the LDH method. The data represent the
mean±S.E.M. of four independent cultures analyzed in triplicate, and the statistical signiﬁcance was determined using one-way ANOVA followed by the Bonferroni post-hoc
test:***Pp0.001versusuntreatedcells,
##Pp0.01versuscellsexposedtoH2O2alone.(c)CBDdecreasedROSproductionunderconditionsofoxidativestress.OPCswere
loaded with DCF-DA for 30min and stimulated with H2O2 in the presence or absence of CBD (1mM). Fluorescence was measured 2h later at 485/530nm in a microplate
reader and the data represent the means±S.E.M. of n¼3 independent cultures analyzed in triplicate. Statistical signiﬁcance was determined using Kruskal–Wallis ANOVA
followed by Mann–Whitney U test: ***Pp0.001 versus untreated cells,
###Pp0.001 versus cells exposed to H2O2 alone
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Cell Death and Diseaseprovoke cytotoxic effects,
8 although no such Ca
2þ inﬂux was
observed here on exposure to 1mM CBD. These conﬂicting
ﬁndings may reﬂect the different source of oligodendrocytes
(optic nerve versus encephalon) and/or the state of differ-
entiation of the cells (mature oligodendrocytes versus
progenitors), pointing out to a different effect of CBD
depending on the developmental state of the cell. Although
CBD has previously been implicated in the regulation of the
cell cycle,
1 we ruled out this possibility by studying BrdU
incorporation and cell cycle progression. Importantly, at low
doses, CBD protected OPCs from LPS/IFNg-induced cell
death, evident by the reduction of caspase 3 and the number
of TUNEL
þ cells. Although CBD protected OPCs from
inﬂammatory damage, we did not observe alterations neither
in nitrites nor NOS-2 induction by LPS/IFN-g, indicating the
lack of participation of NO in the protective effects of CBD.
Although CB1 and CB2 receptors were expressed on OPCs,
7
CBD-induced protection of OPCs was not mediated by the
activationofthesereceptors.Blockingofvanilloidreceptorsor
of the nuclear receptor PPARg also had no effect on the
capacity of CBD to protect OPCs from inﬂammatory damage,
precluding the involvement of these receptors. These ﬁndings
are consistent with reports of other effects of CBD that occur
independently of classical and alternative cannabinoid
receptors.
25
CBD protected OPCs from hydrogen peroxide-induced
oxidative stress by diminishing ROS production, consistent
with the antioxidant properties attributed to this compound in
different experimental models.
26 This is an important ﬁnding,
as OPCs are very vulnerable to oxidative stress,
27 considered
to be one of the pathogenic mechanisms underlying
demyelination and axonal damage in MS.
Oligodendrocytes are very sensitive to alterations in ER
homeostasis. Misfolded proteins generate ER stress and
contribute to cell death in pathophysiological conditions, while
mutations affecting the folding of myelin constituents lead to
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Figure 4 OPC death is mediated by ER stress, an effect that is attenuated by CBD through decreased PKR and eiF2a phosphorylation in conditions of inﬂammation.
(a) CBD attenuated tunicamycin-induced OPC death. OPCs were incubated with tunicamycin (1mg/ml) in the presence or absence of CBD (1mM), and cell death was
quantiﬁed 24h later by the LDH method. The data represent the mean±S.E.M. of three independent cultures analyzed in triplicate, and the statistical signiﬁcance was
determined using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: ***Pp0.001 versus untreated cells,
##Pp0.01 versus cells exposed to tunicamycin alone.
(b) Tunicamycin treatment induced the eiF2a phosphorylation, an effect that was attenuated by CBD. OPCs were incubated with tunicamycin (1mg/ml) in the presence or
absenceof CBD(1mM).Totalproteinextractswereprepared5minlaterandthephosphorylated(38kDa)andtotal(38kDa)eiF2awasassessedinwesternblotsprobedwith
speciﬁc antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from four independent cultures analyzed in triplicate, and the statistical
signiﬁcancewasdeterminedusingKruskal–WallisANOVAfollowedbyMann–WhitneyUtest:**Pp0.01versusuntreatedcells,
#Pp0.05versuscellsexposedtotunicamycin
alone. (c and d) Inﬂammation-induced PKR and eiF2a phosphorylation, an effect that was attenuated by CBD. OPCs were treated with LPS/IFNg in the presence or absence
of CBD (1mM). Total protein extracts were prepared 5min later and PKR (phosphorylated, 68kDa; total, 68kDa) and eiF2a (phosphorylated, 38kDa; total, 38kDa)
was assessed in western blots probed with speciﬁc antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from ﬁve cultures, and the
statistical signiﬁcance was determined using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: **Pp0.01 versus untreated cells,
#Pp0.05 versus cells exposed to
LPS/IFNg alone
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28 We investigated the role of ER
stress in OPC death in vitro. Tunicamycin, an ER stressor,
induced OPC cytotoxicity through a mechanism that involved
the phosphorylation of eiF2a, without altering PKR phospho-
rylation, suggesting that the induction of the UPR pathway
with the tunicamycin treatment can be mediated by other ER
transmembrane protein factors such as IRE1a or ATF6.
Activating this pathway has been linked with the develop-
mental status of the cell
10 and here we present evidence of
the detrimental effects of ER stress in OPCs. The ability of
CBD to protect OPCs from the damage caused by ER stress
through decreasing eiF2a phosphorylation highlights
the potential therapeutic properties of this compound in
pathological conditions in which ER homeostasis is compro-
mised, as proposed in neurodegenerative and demyelinating
diseases.
29,30
There is substantial evidence linking inﬂammation with ER
stress through several intracellular pathways.
11,24 In animal
models of MS, IFNg induces ER stress in actively myelinating
oligodendrocytes, leading to apoptosis and abnormalities in
neuronal myelination.
31 Our results point to the crosstalk
between inﬂammation and ER stress in OPCs, as LPS/IFNg-
induced cell death involved the phosphorylation of PKR
and eiF2a and hence, the apoptotic pathway activated
by the UPR. This pathway has been associated with increased
expression of pro-apoptotic factors, such as the CHOP
transcription factor (C/EBP homologous protein)
32 that primarily
promote apoptosis by repressing Bcl-2 expression
33 or by
inducing caspase 12.
34 In OPCs, we found that inﬂammation
involved caspase 3 activation, induced the expression of CHOP
and caspase 12, and altered the balance between Bax and
Bcl-2, implicating ER stress in cell apoptosis.
Our ﬁndings constitute the ﬁrst evidence that CBD protects
OPCs from inﬂammation-induced apoptosis by blocking ER
stress. In inﬂammatory conditions, CBD decreased the levels
of phosphorylated PKR and eiF2a in OPCs. Moreover,
this effect was accompanied by the restoration of CHOP,
caspase 12, Bcl-2 and Bax mRNA to control levels, together
with an increase in GADD34 expression, a negative feedback
regulator of this pathway.
35
In summary, the ﬁndings presented here indicate that low
doses of CBD exert oligoprotective effects in OPCs under
conditions of inﬂammation, oxidative and ER stress. In
conditions of oxidative stress, the protective effect of CBD
was mediated by a decrease in ROS production, while under
neuroinﬂammatory conditions, CBD combated apoptosis
by decreasing ER stress through the modulation of the
PKR-eiF2a pathway. We propose that CBD, a C. sativa
derivative that lacks psychoactive properties, is a good
candidate to protect OPCs from different cytotoxic insults,
with signiﬁcant therapeutic potential for the treatment of
demyelinating pathologies.
Material and Methods
Animals. Animal handling and care was performed in compliance with European
Union guidelines (86/609/EEC) and Spanish regulations (BOE67/8509-12; BOE1201/
2005) regarding the use and care of laboratory animals, and all the protocols were
approved by the local Animal Care and Ethics Committee of the CSIC.
Reagents. Griess reagent (sulfanilamide, N-(1-naphtyl)ethylenediamine), BrdU,
DCFDA, hydrogen peroxide, LPS and tunicamycin were purchased from Sigma-
Aldrich (Madrid, Spain). IFNg was acquired from Peprotech (London, UK), CPZ
from Alexis Biochemicals (Lausen, Sweden), CBD, AM630 and GW9662 from
Tocris (Bristol, UK) and SR1 was kindly provided by Sanoﬁ-Aventis (Montpellier,
France).
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Figure 5 Inﬂammation activates the ER apoptotic pathway in OPCs, an effect that was attenuated by CBD. (a) CBD attenuated the inﬂammation-induced increase in
CHOP expression. (b) The upregulation of caspase 12 expression in conditions of inﬂammation was attenuated by CBD. (c) CBD restores the Bcl-2/Bax balance in OPCs
treated with LPS/IFNg.( d) CBD increases the expression of the negative feedback regulator GADD34 under conditions of inﬂammation. In all cases, OPCs were incubated
with LPS/IFNg in the presence or absence of CBD (1mM). The mRNA expression of each gene was measured 24h later by quantitative RT-PCR and normalized to the
expression of the 18S gene. The data represent the mean±S.E.M. of three independent cultures analyzed in triplicate, and the statistical signiﬁcance was determined using
Kruskal–Wallis ANOVA followed by Mann–Whitney U test: *Po0.05, ***Pp0.001 versus untreated cells; and
#Pp0.05,
##Pp0.01 versus cells exposed to LPS/IFNg alone
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derived from P0–P2 Wistar rats were prepared as described previously,
22,36 with
some modiﬁcations in doi:10.1038/protex.2011.218 (Open Nature exchange
protocols only on line). Cells were plated on poly-D-lysine-coated plates at 50000
cells/cm
2 for western blotting or 25000 cells/cm
2 for other assays, and they were
maintained for 3 days at 371C and 5% CO2 in serum-free deﬁned medium
containing 5ng/ml of growth factors (bFGF and PDGF-AA).
Cell toxicity. Oligodendrocyte death was quantiﬁed by measuring the release
of lactate dehydrogenase (LDH) from damaged cells into the bathing medium 18,
24 and 48h after exposure to hydrogen peroxide, tunicamycin and LPS/IFNg,
respectively, according to the manufacturer’s instructions (cytotoxicity detection kit,
Roche, Manhein, Germany). All experiments compared the cell death induced with
the basal levels of cell death in the cultures.
TUNEL assay. OPCs were seeded on poly-D-lysine-coated coverslips and
maintained for 24h with LPS/IFNg and/or CBD. After they were ﬁxed in 4% PFA,
post-ﬁxed in EtOH/acetic acid for 5min at  201C and maintained in equilibration
buffer for 1min, they were incubated with the TdT enzyme in a reaction buffer for
1h at 371C (Apoptosis detection kit, Chemicon, Millipore Ibe ´rica, Madrid, Spain).
After washing, the coverslips were incubated with the anti-DIG antibody in blocking
solution and counterstained with DAPI. The data represent TUNEL
þ cells as a
percentage of the total number of cells.
Immunocytochemistry. For BrdU analysis, OPCs were seeded on poly-D-
lysine-coated coverslips and incubated with BrdU (10mM) for 24h in the presence
or absence of CBD. Cells were then ﬁxed in 4% PFA for 20min, treated with 2N
HCl for 10min, blocked and incubated with anti-BrdU antibody (DSHB, 1:1000).
After washing, the cells were incubated with an anti-mouse secondary antibody
(1:1000) and counterstained with DAPI. For A2B5 staining, the cells were treated
for 24h with LPS/IFNg in the presence or absence of CBD, incubated in vivo with
anti-A2B5 marker (R&D Systems, Mineapolis, MN, USA, 1:200), ﬁxed in 4% PFA
and incubated with the secondary antibody (1:1000).
Flow cytometry. Freshly isolated OPCs were maintained on uncoated plates for
24h with vehicle or CBD. The cells were then collected, ﬁxed in cold 70% ethanol for
30min, resuspended in phosphate buffer saline (PBS) and incubated with 100mg/ml
Ribonuclease A (Sigma-Aldrich) and 50mg/ml propidium iodide (PI; Sigma-Aldrich) for
30min. Argon laser excitation at 488nm was used to measure PI ﬂuorescence
through a band-pass 616/23nm ﬁlter using a FACSAria ﬂow cytometer (BD
Biosciences, San Diego, CA, USA). Debris and duplets were excluded from the
analysis and a minimum of 10000 cells were acquired in each experiment. FACSDiva
analysis software (BD Biosciences) was used to deﬁne the cell cycle stages.
Measurement of intracellular Ca
2þ. Cells were seeded on coverslips
and incubated for 20–30min at 371C in PBS containing Fluo4-AM (0.3mM,
Invitrogen, Barcelona, Spain) and pluronic F-127 (0.04%, Sigma-Aldrich). The
coverslips were then transferred to the microscope chamber and bathed in an
extracellular medium containing (in mM): NaCl 140, KCl 5, MgCl2 4, HEPES 10,
glucose 10 and sucrose 6 (pH 7.35). All experiments were performed at room
temperature. Cells were imaged with an Olympus (Barcelona, Spain) FV3 scanning
confocal microscope equipped with a  40 objective (NA, 0.8) and laser emission at
488nm was used to excite Fluo-4. The ﬂuorescent signal recorded is displayed as a
pseudocolor image and the look-up-table used is indicated in each ﬁgure. The time
frame acquisition was 1.12s.
ROS determination. OPCs were loaded with dichlorodihydroﬂuorescein
diacetate acetyl ester (DCFDA, 2mM) for 30min, washed and stimulated with
hydrogen peroxide for 2h or with LPS/IFNg for 24h in the presence or absence of
CBD. Fluorescence was measured at 485/530nm in a microplate reader and
normalized to the negative control.
Western blot analysis. Western blot analysis was performed as previously
described
7 using 30–40mg of OPC protein extract and an anti-cleaved caspase3
(Asp
175; 1:1000, Cell Signaling Technology, Denvers, MA, USA), anti-phospho
(Ser
51) eIF2a (1:1000; Cell Signaling Technology), anti-total eIF2a (1:1000; Cell
Signaling Technology), anti-phospho (Thr
446) PKR (1:1000, Upstate, Millipore
Ibe ´rica, Madrid, Spain) and anti-total PKR (1:1000, Millipore, Madrid, Spain). Anti-
a-tubulin (1:40000; Sigma-Aldrich) was used as a loading control.
RNA extraction, reverse transcription and RT-PCR. Total OPC
RNA was extracted using the RNeasy mini columns kit (Qiagen, Crawley, UK) and
treated with DNaseI (Qiagen), and the RNA concentration and purity were
determined in a Nanodrop spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA). Total RNA (1mg) was reverse transcribed using the
Promega reverse transcription kit (Promega, Madrid, Spain) and RT-PCR was
performed on 1ml of cDNA (corresponding to 50ng RNA input) with 200nM of the
primers listed below (Applied Biosystems, Warrington, UK), quantifying expression
using SYBR Green (Applied Biosystems). The ampliﬁcation cycles involved an
initial activation step at 501C for 2min and a denaturation step at 951C for 10min,
followed by 40 cycles of denaturation at 951C for 15s and annealing/extension at
601C for 1min. PCR assays were carried out in 96-well plates using a 7500 Real-
Time PCR system (Applied Biosystems). Each sample was assayed in duplicate
and a 6-point standard curve was run in parallel. The ratio between the values
obtained for each gene and the 18S house-keeping gene provided a relative
quantiﬁcation of expression. The 50-30primer secuences used were the following:
CHOP (forward 50-CCAAAATAACAGCCGGAACCT-30; reverse 50-CAAAGGCG
AAAGGCAGAGACT-30), GADD34 (forward 50-AGCATGGACACGCCTTAGA
AA-30; reverse 50-AGGCTGGGAGGAGGGATTT-30), Bax (forward 50-GGGT
GGCAGCTGACATGTTT-30; reverse 50-TGATCAGCTCGGGCACTTTA-30), Bcl-2
(forward 50-TGAGAGCAACCGAACGCCCG-30; reverse 50-CCGTGGCAAAG
CGTCCCCTC-30), caspase 12 (forward 50-GAAGGAAGGCCGAACCCGCC-30;
reverse 50-TGCTCTGGACGGCCAGCAAAC-30) and 18S (forward 50-ATGCTCTT
AGCTGAGTGTCCCG-30; reverse 50-ATTCCTAGCTGCGGTATCCAGG-30)
Data analysis. All data are expressed as the mean±S.E.M. (n), where
n refers to the number of cultures assayed, each obtained from a different group of
animals and evaluated in triplicate. One-way ANOVA followed by the Bonferroni
post-hoc test, or Kruskal—Wallis ANOVA followed by Mann–Whitney U test was
used to determine the statistical signiﬁcance in all cases. The level of signiﬁcance
was set at Po0.05.
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